Stockscreener 앱 받기
0.6459
0.17%
0.0011
전일 마감가:
$0.6448
열려 있는:
$0.65
하루 거래량:
284.20K
Relative Volume:
0.52
시가총액:
$27.11M
수익:
$3.26M
순이익/손실:
$-19.52M
주가수익비율:
-1.6148
EPS:
-0.4
순현금흐름:
$-24.10M
1주 성능:
-1.48%
1개월 성능:
+9.34%
6개월 성능:
-21.42%
1년 성능:
-41.81%
1일 변동 폭
$0.6346
$0.6549
1주일 범위
$0.634
$0.6695
52주 변동 폭
$0.565
$1.49
Scynexis Inc Stock (SCYX) Company Profile
명칭
Scynexis Inc
전화
201-884-5485
주소
1 EVERTRUST PLAZA, JERSEY CITY, NJ
SCYX을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
SCYX
Scynexis Inc
|
0.6459 | 27.06M | 3.26M | -19.52M | -24.10M | -0.40 |
|
ZTS
Zoetis Inc
|
118.66 | 51.85B | 9.40B | 2.65B | 2.24B | 5.935 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.33 | 45.46B | 29.63B | 260.53M | 5.51B | 0.0788 |
|
HLN
Haleon Plc Adr
|
9.52 | 42.70B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
29.79 | 34.62B | 16.88B | 666.71M | 251.19M | 0.6132 |
|
UTHR
United Therapeutics Corp
|
493.99 | 21.03B | 3.08B | 1.24B | 1.07B | 25.61 |
Scynexis Inc Stock (SCYX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2021-01-22 | 개시 | Guggenheim | Buy |
| 2021-01-06 | 개시 | Cantor Fitzgerald | Overweight |
| 2018-07-11 | 업그레이드 | Needham | Hold → Buy |
| 2018-06-27 | 개시 | Maxim Group | Buy |
| 2017-10-24 | 개시 | Guggenheim | Buy |
| 2017-07-10 | 개시 | ROTH Capital | Buy |
| 2017-05-09 | 다운그레이드 | Needham | Buy → Hold |
| 2017-03-03 | 재확인 | RBC Capital Mkts | Outperform |
| 2016-10-20 | 개시 | H.C. Wainwright | Buy |
| 2016-10-07 | 업그레이드 | WBB Securities | Buy → Strong Buy |
| 2016-10-03 | 재개 | Brean Capital | Buy |
| 2016-08-17 | 개시 | Guggenheim | Buy |
| 2016-08-09 | 재확인 | Needham | Buy |
| 2016-08-09 | 업그레이드 | WBB Securities | Speculative Buy → Buy |
| 2016-03-28 | 개시 | Brean Capital | Buy |
| 2015-12-29 | 개시 | WBB Securities | Speculative Buy |
| 2015-11-16 | 재확인 | RBC Capital Mkts | Outperform |
| 2015-06-10 | 개시 | Needham | Buy |
| 2014-05-29 | 개시 | Canaccord Genuity | Buy |
| 2014-05-29 | 개시 | RBC Capital Mkts | Outperform |
모두보기
Scynexis Inc 주식(SCYX)의 최신 뉴스
SCYNEXIS (NASDAQ:SCYX) versus NewAmsterdam Pharma (NASDAQ:NAMS) Head to Head Analysis - Defense World
Can SCYNEXIS Stock Hold Up When Markets Turn? - Trefis
Can SCYNEXIS Inc. stock surprise with earnings upsideVolume Spike & Real-Time Price Movement Reports - Newser
Why SCYNEXIS Inc. (135A) stock stays resilientWeekly Stock Report & Smart Swing Trading Techniques - Newser
How SCYNEXIS Inc. stock trades before earnings2025 Breakouts & Breakdowns & Low Drawdown Momentum Ideas - Newser
SCYNEXIS (NASDAQ:SCYX) Stock Price Crosses Below 200-Day Moving Average – Should You Sell? - Defense World
What is the fair value of SCYNEXIS Inc. stock nowEarnings Performance Report & Free Low Drawdown Momentum Trade Ideas - Newser
Is SCYNEXIS Inc. (135A) stock considered safe havenDollar Strength & Low Risk Investment Opportunities - Newser
Free cash flow per share of SCYNEXIS, Inc. – LSE:0L49 - TradingView
Working capital per share of SCYNEXIS, Inc. – LSE:0L49 - TradingView
Macro Review: Why SCYNEXIS Inc. stock is trending among retail tradersJuly 2025 Retail & Risk Adjusted Buy and Sell Alerts - moha.gov.vn
Why SCYNEXIS Inc. stock is a must watch in 2025Portfolio Gains Report & Community Verified Swing Trade Signals - moha.gov.vn
Why SCYNEXIS Inc. (135A) stock is listed among top recommendationsQuarterly Portfolio Review & Risk Managed Investment Entry Signals - BỘ NỘI VỤ
Is SCYNEXIS Inc a good long term investmentGrowth Stock Opportunities & Exceptional Return Growth - earlytimes.in
Is SCYNEXIS Inc. stock trading at a premium valuation2025 Short Interest & Stepwise Entry and Exit Trade Signals - BỘ NỘI VỤ
It is Poised to be a Bull Market for Scynexis Inc (SCYX) - Setenews
12 Health Care Stocks Moving In Tuesday's Pre-Market Session - Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session - Benzinga
Investors in cash trouble should check out Scynexis Inc (SCYX) - Setenews
Will SCYNEXIS Inc. (135A) stock outperform foreign stocksJuly 2025 Action & Risk Managed Trade Strategies - newser.com
Scynexis announces grant for Hackensack Meridian, Johns Hopkins collaboration - MSN
Analyzing recovery setups for SCYNEXIS Inc. investorsFed Meeting & Fast Gain Stock Trading Tips - newser.com
Will SCYNEXIS Inc. stock recover faster than peersJuly 2025 Update & Technical Pattern Alert System - newser.com
Scynexis Transfers Brexafemme New Drug Application to GSK - MarketScreener
SCYNEXIS, Inc. Completes Transfer of Brexafungerp New Drug Application to Gsk - MarketScreener
Scynexis completes transfer of Brexafemme new drug application to GSK - MarketScreener
SCYNEXIS Completes BREXAFEMME NDA Transfer to GSK, Positioning for Future Milestones and Royalties - Quiver Quantitative
SCYNEXIS Completes Transfer of BREXAFEMME® New Drug Application to GSK - The Manila Times
Scynexis completes transfer of Brexafemme New Drug Application To GSK - TradingView
SCYNEXIS (NASDAQ: SCYX) transfers BREXAFEMME NDA to GSK, up to $145.5M - Stock Titan
Is SCYNEXIS Inc. stock attractive for passive investorsMarket Sentiment Report & Long-Term Safe Investment Plans - newser.com
GSK Completes Acquisition of BREXAFEMME NDA for U.S. Market Rela - GuruFocus
How to build a dashboard for SCYNEXIS Inc. stockEarnings Overview Report & Risk Controlled Daily Trade Plans - newser.com
Scynexis fungerps among funding recipients - BioWorld MedTech
SCYNEXIS receives $7 million annual grant for antifungal research By Investing.com - Investing.com Nigeria
SCYX Secures Federal Grant for Antifungal Research - GuruFocus
Scynexis Announces Federal Funding of Collaboration Between Hackensack Meridian CDI and Johns Hopkins Researchers to Develop New Therapeutics, Including Novel Fungerps, for Resistant Fungal Infections - The Manila Times
SCYNEXIS Receives $35 Million NIH Grant to Develop Next-Generation Antifungal Therapies - Quiver Quantitative
Scynexis (NASDAQ: SCYX) fungerps program included in $7M NIH CETR grant - Stock Titan
Why SCYNEXIS Inc. (135A) stock benefits from AI revolutionForecast Cut & AI Forecast Swing Trade Picks - newser.com
Live market analysis of SCYNEXIS Inc.July 2025 Recap & Community Verified Trade Signals - newser.com
Will SCYNEXIS Inc. (135A) stock deliver stable dividendsJuly 2025 Closing Moves & Weekly Top Gainers Alerts - newser.com
How geopolitical tensions affect SCYNEXIS Inc. stockEarnings Recap Summary & Consistent Return Investment Signals - newser.com
Scynexis Inc (SCYX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.48%
0.09%
자본화:
|
볼륨(24시간):